NASDAQ:LGND - Ligand Pharmaceuticals Incorporated
$111.76
 $-1.79
-1.58%
4:00PM EDT
2019-07-22
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  LGND     avg for
industry  
  avg for
sector  
42 stocks weight:  264. 74   0. 00   0. 00  
42 stocks rank:  262. 00   1. 35 K 799. 74  
# analyst opinions:  5. 00   12. 76   13. 14  
mean recommendation:  2. 00   2. 11   2. 07  

quick ratio:  8. 18   5. 61   1. 85  
current ratio:  8. 39   6. 00   2. 31  

ex-dividend date:     2010-07-01
target price low:  131. 00   75. 88   108. 31  
target price avg:  197. 00   97. 27   130. 10  
target price high:  230. 00   124. 58   149. 02  
1-yr high:  274. 49   104. 89   135. 09  
last close:  111. 76   79. 79   118. 76  
50-day avg:  113. 39   79. 39   116. 18  
200-day avg:  134. 03   81. 61   114. 52  
1-yr low:  105. 93   62. 76   94. 70  
volume:  207. 63 K 2. 99 M 4. 43 M
50-day avg volume:  309. 20 K 3. 39 M 4. 22 M
200-day avg volume:  576. 95 K 3. 13 M 4. 83 M

1-day return:  -1. 58 % 0. 33 % 0. 14 %
this week return:  -1. 58 % 0. 33 % 0. 14 %
12-wk return:  -8. 10 % 1. 00 % 3. 51 %
52-wk return:  -50. 07 % 0. 58 % 10. 25 %

enterprise value (EV):  1. 37 B 44. 78 B 115. 63 B
market cap:  2. 19 B 38. 01 B 103. 29 B
EBITDA:  157. 23 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  8. 73   2. 11   11. 26  
enterprise/revenue (EV/R):  5. 75   61. 53   10. 40  
total revenue:  238. 78 M 10. 43 B 31. 15 B
total debt:  649. 25 M 11. 72 B 16. 76 B
debt/equity:  60. 12   61. 22   124. 43  
net income (common):  764. 38 M 2. 06 B 3. 79 B

shares outstanding:  19. 60 M 562. 08 M 1. 27 B
shares:  17. 61 M 573. 33 M 1. 26 B
shares short:  6. 78 M 11. 60 M 12. 29 M
shares short prior month:  6. 92 M 9. 81 M 12. 46 M
short ratio:  19. 00   5. 88   3. 41  
short % of float:  41. 74 % 6. 88 % 2. 72 %
total cash/share:  76. 61   10. 62   8. 83  
total cash:  1. 50 B 6. 17 B 5. 72 B
free cash flow:  1. 07 B 3. 08 B 3. 10 B
operating cash flow:  178. 56 M 3. 99 B 4. 08 B

book value:  54. 92   12. 74   26. 25  
price/book:  2. 03   4. 38   9. 01  
gross profits:  217. 25 M 7. 93 B 35. 64 B
operating margins:  58. 81 % -319. 65 % -29. 05 %
EBITDA margins:  65. 85 % 11. 82 % 24. 13 %
profit margins:  320. 12 % 5. 62 % 14. 29 %
gross margins:  82. 77 % 34. 75 % 57. 07 %

1-yr max volatility:  16. 28 % --- ---
1-yr mean volatility:  2. 08 % 1. 95 % 1. 25 %

1-yr EPS:  32. 97   1. 58   3. 82  
forward EPS:  3. 77   3. 16   6. 65  
P/E:  3. 39   0. 21   31. 97  
forward P/E:  30. 12   4. 95   15. 14  
PE/G:  0. 01   0. 74   0. 13  
growth:  325. 95 % 295. 81 % 85. 47 %
earnings high:  0. 65   0. 84   1. 56  
earnings avg:  0. 55   0. 65   1. 45  
earnings low:  0. 38   0. 40   1. 35  
revenue high:  23. 94 M 2. 70 B 8. 76 B
revenue avg:  21. 01 M 2. 64 B 8. 62 B
revenue low:  17. 28 M 2. 58 B 8. 45 B
earnings growth:  1611. 50 % 10. 83 % 36. 30 %
1-qtr earnings growth:  1371. 60 % 8. 21 % 35. 90 %
return on assets:  6. 58 % -3. 43 % 4. 51 %
return on equity:  96. 93 % -104. 30 % 140. 44 %
revenue growth:  -22. 60 % 295. 25 % 78. 55 %
revenue/share:  11. 39   12. 50   51. 58  

beta (1yr vs S&P500):  1. 53   1. 27   0. 91  
sharpe (1yr):  -1. 36   0. 20   0. 80  

held % insiders:  3. 44 % 6. 63 % 3. 46 %
held % institutions:  130. 68 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : LGND
.    144.735 =       144.735 :: --> INITIAL WEIGHT <--
.    + 32.97 =       177.705 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.893 =       514.085 :: P/E factor
.    x 2.209 =      1135.593 :: PE/G factor
.    x 1.621 =      1841.029 :: beta factor
.    x 0.832 =      1531.172 :: sharpe factor
.    x 2.602 =      3983.376 :: current ratio factor
.    x 1.067 =      4251.694 :: quick ratio factor
.    x 1.026 =      4362.146 :: short ratio factor
.    x 1.163 =      5075.023 :: return on assets factor
.    x 2.164 =     10982.864 :: return on equity factor
.     x 4.05 =     44477.822 :: earnings growth factor
.    x 1.093 =     48634.907 :: EV/R factor
.     x 1.01 =     49127.247 :: price-to-book factor
.     x 1.81 =      88938.63 :: EBITDA factor
.    x 1.807 =    160754.231 :: EBITDA vs industry factor
.     x 0.77 =    123823.053 :: debt-to-revenue factor
.    x 1.408 =    174320.297 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.759 =    480990.634 :: sector+industry 1-year gains factor
.     x 1.01 =    485793.352 :: industry 12-weeks return factor
.    x 1.309 =    636081.529 :: industry 2-weeks return factor
.    x 0.884 =    562080.377 :: company one-year gains+dividend factor
.    x 2.564 =   1441147.563 :: company 13 weeks' performance factor
.    x 1.019 =    1468440.87 :: 5-day avg > 50-day avg
.    x 0.979 =   1438310.336 :: "drift" penalty 2 days ago
.    x 0.998 =   1436085.555 :: "drift" penalty 3 days ago
.    / 1.881 =    763548.943 :: overall "drift" factor
.    x 0.914 =    697510.695 :: largest single-day jump factor
.    x 0.992 =    692235.412 :: volatility factor
.    x 0.994 =    687990.275 :: 42-day volatility factor
.    x 3.218 =   2214022.282 :: notable returns + performance factor
.    x 3.407 =   7542719.129 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.372 =  10345513.864 :: forward EPS factor
.    x 1.881 =  19460638.967 :: forward P/E factor
.    x 1.184 =  23040617.726 :: industry recommendation factor
.     x 2.16 =  49757978.569 :: company recommendation factor
.    x 1.002 =  49833578.111 :: factor historical industry gain for week 29
.    x 1.515 =  75487536.432 :: target low factor
.    x 1.291 =  97462720.499 :: target mean factor
.    x 1.043 = 101673154.209 :: target high factor
.    x 5.177 =  526394089.02 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        151.47 :: reduced for readability
.   + 88.618 =       240.089 :: add/subtract for investor sentiment
.   + 24.647 =       264.736 :: earnings report in 8 days
.                               --> FINAL WEIGHT <--
.                    264.736 :: FINAL WEIGHT for NASDAQ:LGND


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org